Skip to main content
Explore URMC

Wilmot Cancer Institute Logo

menu
Aram Francis Hezel, M.D.
Aram Francis Hezel, M.D.

Aram Francis Hezel, M.D.

Medicine — Hematology/Oncology

Accepting New Patients

Aram Francis Hezel, M.D.

Medicine — Hematology/Oncology

Accepting New Patients


Locations

James P. Wilmot Cancer Center
601 Elmwood Ave.
Rochester, NY 14642
Get Directions

phone

Appointments

(585) 275-5823

print

Fax

(585) 273-1042

About Me

I chose this field because as a young man, I was profoundly impacted by the death of my grandfather from cancer, and then later in medical school, I was drawn at a scientific and personal level to the care of people facing cancer.
?Every patient is different – and so is each cancer. Doing the best I can to understand patients and their families, what is important to them and providing the best possible care is my goal. While many people face cancer, each person does so with specific concerns, fears and beliefs. I will always do my best to provide the highest quality care, while preserving a patient's dignity.

My areas of special interest include clinical trials with new therapies for gastrointestinal cancers, and understanding the genetics and biology of pancreatic and liver cancers.

Conditions I Treat

- Esophageal cancer
- Stomach cancer
- Liver cancer
- Pancreatic cancer
- Bowel cancer
- Colon cancer
- Rectal cancer
- Anal cancer
- Gastrointestinal stromal tumors (GIST)
- Neuroendocrine tumors
- Carcinoid tumors

Credentials

Education:

MD | SUNY Buffalo School of Medicine — 2000

Post-doctoral Training & Residency:

Residency in Internal Medicine at Beth Israel Deaconess Medical Center — 2001 - 2003
Internship in at Beth Israel Deaconess Medical Center — 2000 - 2001
Fellowship in Medical Oncology at Dana Farber Cancer Institute/ Partners — 2003 - 2006

Research

Publications:

Saha SK, Parachoniak CA, Ghanta KS, Fitamant J, Ross KN, Najem MS, Gurumurthy S, Akbay EA, Sia D, Cornella H, Miltiadous O, Walesky C, Deshpande V, Zhu AX, Hezel AF, Yen KE, Straley KS, Travins J, Popovici-Muller J, Gliser C, Ferrone CR, Apte U, Llovet JM, Wong KK, Ramaswamy S, Bardeesy N. "Mutant IDH inhibits HNF-4? to block hepatocyte differentiation and promote biliary cancer." Nature. 2014; 10.1038/nature13441.

Hezel AF, Noel MS, Allen JN, Abrams TA, Yurgelun M, Faris JE, Goyal L, Clark JW, Blaszkowsky LS, Murphy JE, Zheng H, Khorana AA, Connolly GC, Hyrien O, Baran A, Herr M, Ng K, Sheehan S, Harris DJ, Regan E, Borger DR, Iafrate AJ, Fuchs C, Ryan DP, Zhu AX. "Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer. ." Br J Cancer.;111(3):430-6. doi: 10.1038/bjc.2014.343. Epub 2014 Jun 24. 2014; .

Connolly GC, Safadjou S, Kashyap R, Chen R, Orloff MS, Hezel AF. "Diabetes mellitus impacts risk of macrovascular invasion in patients undergoing transplantation for hepatocellular carcinoma." BMC Gastroenterology. 2013; : 139.

View All Publications